
Eisai
Asia, Tokyo, Japan, Tokyo
Description
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Investor Profile
Eisai has backed more than 8 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 25% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Japan, Singapore.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
- Led 1 rounds in the past year.
Stage Focus
- Series A (50%)
- Series C (25%)
- Series Unknown (13%)
- Pre Seed (13%)
Country Focus
- United States (38%)
- Japan (25%)
- Singapore (25%)
- Finland (13%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Medical
- Artificial Intelligence (Ai)
- Bioinformatics
- Clinical Trials
- Mobile Apps
- Wearables
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Eisai frequently co-invest with?
Which angels does Eisai often collaborate with?
What are some of recent deals done by Eisai?
Find More Investors Like Eisai
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










